(Taken from the application): The major goal of the Molecular Histology Core B is to provide histological service to investigators in the Program Project grant.
Our specific aims are (1) to measure by static and dynamic histomorphometry bone formation and resorption in murine bones, (2) to quantify bone mass and structure in murine bones using microcomputed tomography, as well as in the skeleton of living animals using peripheral quantitated computed tomography, (3) to ,quantify bone mechanical integrity using flexure and/or torsion tests to failure using a mechanical test system capable of tension-compression and/or torsion, (4) to analyze by immunofluorescence microscopy or immunohistochemistry the localization and extent of expression of bone factors and cytokines in bone from transgenic mice, carrying different promoter-reporter constructs or mice lacking or overexpressing specific receptors, and (5) to develop new histological techniques to substantiate and to elaborate further the results obtained by molecular biological and biochemical assays by investigators in the Program Project grant. The Molecular Histology Core is able to provide an efficient and specialized service that would not be possible for individual investigators to develop without a major investment of time, new personnel and money. The Core will develop a centralized data base on skeletal changes in transgenic mice for use by investigators at the University of Connecticut Health Center and eventually by other institutions. New information will be generated on the function of bone cells involved in growth, development and musculoskeletal diseases, such as osteoporosis.

Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Marijanovic, Inga; Kronenberg, Mark S; Erceg Ivkosic, Ivana et al. (2009) Comparison of proliferation and differentiation of calvarial osteoblast cultures derived from Msx2 deficient and wild type mice. Coll Antropol 33:919-24
Zhang, W; Pantschenko, A G; McCarthy, M-B et al. (2007) Bone-targeted overexpression of Bcl-2 increases osteoblast adhesion and differentiation and inhibits mineralization in vitro. Calcif Tissue Int 80:111-22
Jiang, Jin; Lichtler, Alexander C; Gronowicz, Gloria A et al. (2006) Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39:494-504
Lee, Sun-Kyeong; Gardner, Amy E; Kalinowski, Judith F et al. (2006) RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production. Bone 38:678-85
He, Jianing; Rosen, Clifford J; Adams, Douglas J et al. (2006) Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. Bone 38:826-35
Lengner, Christopher J; Steinman, Heather A; Gagnon, James et al. (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172:909-21
Delahunty, K M; Shultz, K L; Gronowicz, G A et al. (2006) Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 147:3915-23
Sher, L B; Harrison, J R; Adams, D J et al. (2006) Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif Tissue Int 79:118-25
Pantschenko, Alexander G; Zhang, Wenjian; Nahounou, Marcia et al. (2005) Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J Bone Miner Res 20:1414-29
Kim, Nacksung; Kadono, Yuho; Takami, Masamichi et al. (2005) Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 202:589-95

Showing the most recent 10 out of 94 publications